294 related articles for article (PubMed ID: 35472303)
21. Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP Study.
Svennberg E; Engdahl J; Al-Khalili F; Friberg L; Frykman V; Rosenqvist M
Circulation; 2015 Jun; 131(25):2176-84. PubMed ID: 25910800
[TBL] [Abstract][Full Text] [Related]
22. Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program.
McIntyre WF; Conen D; Olshansky B; Halperin JL; Hayek E; Huisman MV; Lip GYH; Lu S; Healey JS
Clin Cardiol; 2018 Jun; 41(6):744-751. PubMed ID: 29546729
[TBL] [Abstract][Full Text] [Related]
23. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study.
Hobbs FD; Fitzmaurice DA; Mant J; Murray E; Jowett S; Bryan S; Raftery J; Davies M; Lip G
Health Technol Assess; 2005 Oct; 9(40):iii-iv, ix-x, 1-74. PubMed ID: 16202350
[TBL] [Abstract][Full Text] [Related]
24. Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration.
Schnabel RB; Haeusler KG; Healey JS; Freedman B; Boriani G; Brachmann J; Brandes A; Bustamante A; Casadei B; Crijns HJGM; Doehner W; Engström G; Fauchier L; Friberg L; Gladstone DJ; Glotzer TV; Goto S; Hankey GJ; Harbison JA; Hobbs FDR; Johnson LSB; Kamel H; Kirchhof P; Korompoki E; Krieger DW; Lip GYH; Løchen ML; Mairesse GH; Montaner J; Neubeck L; Ntaios G; Piccini JP; Potpara TS; Quinn TJ; Reiffel JA; Ribeiro ALP; Rienstra M; Rosenqvist M; Themistoclakis S; Sinner MF; Svendsen JH; Van Gelder IC; Wachter R; Wijeratne T; Yan B
Circulation; 2019 Nov; 140(22):1834-1850. PubMed ID: 31765261
[TBL] [Abstract][Full Text] [Related]
25. Practice Variation in Anticoagulation Prescription and Outcomes After Device-Detected Atrial Fibrillation.
Perino AC; Fan J; Askari M; Heidenreich PA; Keung E; Raitt MH; Piccini JP; Ziegler PD; Turakhia MP
Circulation; 2019 May; 139(22):2502-2512. PubMed ID: 30880434
[TBL] [Abstract][Full Text] [Related]
26. Rationale and Design of the Evaluation of Oral Anticoagulation for Reduction of Thrombo-embolism in Chinese Patients with Device-Detected Subclinical Atrial Fibrillation (ART-CAF) Trial: an Open-Label Registry-Based Clinical Trial.
Yang Y; Xu F; Tong J; Cai L; Jiang W; Sheng X; Pan Y; Jiang J; Zhang J; Jiang D; Zhao L; Fu G
Cardiovasc Drugs Ther; 2018 Aug; 32(4):389-396. PubMed ID: 30027309
[TBL] [Abstract][Full Text] [Related]
27. Outcomes of Patients With Atrial Fibrillation Newly Recommended for Oral Anticoagulation Under the 2014 American Heart Association/American College of Cardiology/Heart Rhythm Society Guideline.
Gray MP; Saba S; Zhang Y; Hernandez I
J Am Heart Assoc; 2018 Jan; 7(1):. PubMed ID: 29301756
[TBL] [Abstract][Full Text] [Related]
28. Screening for Atrial Fibrillation in Older Adults at Primary Care Visits: VITAL-AF Randomized Controlled Trial.
Lubitz SA; Atlas SJ; Ashburner JM; Lipsanopoulos ATT; Borowsky LH; Guan W; Khurshid S; Ellinor PT; Chang Y; McManus DD; Singer DE
Circulation; 2022 Mar; 145(13):946-954. PubMed ID: 35232217
[TBL] [Abstract][Full Text] [Related]
29. Severity and Etiology of Incident Stroke in Patients Screened for Atrial Fibrillation vs Usual Care and the Impact of Prior Stroke: A Post Hoc Analysis of the LOOP Randomized Clinical Trial.
Diederichsen SZ; Frederiksen KS; Xing LY; Haugan KJ; Højberg S; Brandes A; Graff C; Olesen MS; Krieger D; Køber L; Svendsen JH
JAMA Neurol; 2022 Oct; 79(10):997-1004. PubMed ID: 36036546
[TBL] [Abstract][Full Text] [Related]
30. Decision-Making in Clinical Practice: Oral Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation and a Single Additional Stroke Risk Factor.
Potpara TS; Dagres N; Mujović N; Vasić D; Ašanin M; Nedeljkovic M; Marin F; Fauchier L; Blomstrom-Lundqvist C; Lip GY
Adv Ther; 2017 Feb; 34(2):357-377. PubMed ID: 27933569
[TBL] [Abstract][Full Text] [Related]
31. Automated Software System to Promote Anticoagulation and Reduce Stroke Risk: Cluster-Randomized Controlled Trial.
Holt TA; Dalton A; Marshall T; Fay M; Qureshi N; Kirkpatrick S; Hislop J; Lasserson D; Kearley K; Mollison J; Yu LM; Hobbs FD; Fitzmaurice D
Stroke; 2017 Mar; 48(3):787-790. PubMed ID: 28119433
[TBL] [Abstract][Full Text] [Related]
32. Atrial fibrillation detected by continuous electrocardiographic monitoring using implantable loop recorder to prevent stroke in individuals at risk (the LOOP study): Rationale and design of a large randomized controlled trial.
Diederichsen SZ; Haugan KJ; Køber L; Højberg S; Brandes A; Kronborg C; Graff C; Holst AG; Nielsen JB; Krieger D; Svendsen JH
Am Heart J; 2017 May; 187():122-132. PubMed ID: 28454796
[TBL] [Abstract][Full Text] [Related]
33. Incremental yield of ECG screening repeated annually over 4 years in an adult Japanese population without prior atrial fibrillation: a retrospective cohort study.
Nagata Y; Yamagami T; Nutbeam D; Freedman B; Lowres N
BMJ Open; 2020 Jul; 10(7):e035650. PubMed ID: 32690510
[TBL] [Abstract][Full Text] [Related]
34. Contemporary prevalence estimates of undiagnosed and diagnosed atrial fibrillation in the United States.
Turakhia MP; Guo JD; Keshishian A; Delinger R; Sun X; Ferri M; Russ C; Cato M; Yuce H; Hlavacek P
Clin Cardiol; 2023 May; 46(5):484-493. PubMed ID: 36855960
[TBL] [Abstract][Full Text] [Related]
35. Ischemic and Bleeding Outcomes in Patients With Atrial Fibrillation and Contraindications to Oral Anticoagulation.
Steinberg BA; Ballew NG; Greiner MA; Lippmann SJ; Curtis LH; O'Brien EC; Patel MR; Piccini JP
JACC Clin Electrophysiol; 2019 Dec; 5(12):1384-1392. PubMed ID: 31857036
[TBL] [Abstract][Full Text] [Related]
36. Oral anticoagulant therapy in atrial fibrillation patients at high stroke and bleeding risk.
Potpara TS; Lip GY
Prog Cardiovasc Dis; 2015; 58(2):177-94. PubMed ID: 26162958
[TBL] [Abstract][Full Text] [Related]
37. Left atrial appendage occlusion vs novel oral anticoagulation for stroke prevention in atrial fibrillation: rationale and design of the multicenter randomized occlusion-AF trial.
Korsholm K; Damgaard D; Valentin JB; Packer EJS; Odenstedt J; Sinisalo J; Putaala J; Næss H; Al-Jazi MA; Karlsson JE; Pontoppidan J; Modrau B; Hjort J; Matzen KL; Johnsen SP; Nielsen-Kudsk JE
Am Heart J; 2022 Jan; 243():28-38. PubMed ID: 34537184
[TBL] [Abstract][Full Text] [Related]
38. Atrial fibrillation patient preferences for oral anticoagulation and stroke knowledge: Results of a conjoint analysis.
Lane DA; Meyerhoff J; Rohner U; Lip GYH
Clin Cardiol; 2018 Jun; 41(6):855-861. PubMed ID: 29696664
[TBL] [Abstract][Full Text] [Related]
39. Mobile phones in cryptogenic strOke patients Bringing sIngle Lead ECGs for Atrial Fibrillation detection (MOBILE-AF): study protocol for a randomised controlled trial.
Treskes RW; Gielen W; Wermer MJ; Grauss RW; van Alem AP; Dehnavi RA; Kirchhof CJ; van der Velde ET; Maan AC; Wolterbeek R; Overbeek OM; Schalij MJ; Trines SA
Trials; 2017 Aug; 18(1):402. PubMed ID: 28851409
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients With Atrial Fibrillation.
O'Brien EC; Holmes DN; Thomas LE; Fonarow GC; Allen LA; Gersh BJ; Kowey PR; Singer DE; Ezekowitz MD; Naccarelli GV; Ansell JE; Chan PS; Mahaffey KW; Go AS; Freeman JV; Reiffel JA; Peterson ED; Piccini JP; Hylek EM
Circulation; 2018 Aug; 138(9):889-897. PubMed ID: 29678813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
